We cover a range of clinical trial studies in different therapy areas and conditions, which do change periodically. Register your interest with Bioluminux, or read about our trials below to find out more. If you have any queries about specific research, please get in touch with us directly or visit our FAQs section for more details.
Register Interest
Adults with overweight or obesity may be eligible to participate in a clinical research study evaluating an investigational GLP-1 treatment for weight management.
You may qualify if you:
Are 18 years of age or older
Have overweight or obesity
Do not have any type of diabetes
Meet additional study eligibility requirements, which will be reviewed during your screening visit
Qualified participants may receive study-related care at no cost. Compensation for time and travel may be available.
Interested in Participating? Click here to see if you may qualify.
Do you have COPD?
Bioluminux Clinical Research is conducting a research study evaluating an investigational antiviral medication that may help reduce the severity and duration of symptoms caused by common cold viruses in people living with COPD.
You may qualify if you:
Are between 40 and 85 years of age
Have been diagnosed with COPD by a healthcare provider
Are currently taking medication for COPD
Have experienced at least one COPD flare-up (exacerbation) within the past 12 months
Interested in Participating? Select your preferred study location to begin the screening process.
Do you have high blood pressure that remains uncontrolled despite taking regular medication? You may be able to join a clinical research study testing an investigational treatment
This study is designed for adults with uncontrolled hypertension who also have established cardiovascular disease (such as heart attack, stroke, or artery disease) or are at high risk of developing cardiovascular disease. The trial will evaluate whether a test medication, given once every 6 months in addition to current standard treatments, can help reduce the risk of major cardiovascular events such as heart attack, stroke, or hospitalization for heart failure
Those who qualify may receive:
Investigational treatment or placebo in addition to current medication
Regular blood pressure checks, heart health monitoring, and safety assessments
Care and support from a dedicated research team
Reimbursement for time and travel expenses
An opportunity to contribute to new research in high blood pressure and heart health
Chronic kidney disease is a common condition, but many people who are living with it don't know that they have it.People in the Black Community are at a higher risk of developing APOL-1 mediate kidney disease.
If you have chronic kidney disease or kidney problems run in your family and are of African descent, you may be able to participate in a clinical research study for APOL1-mediated kidney disease.
Living with vitiligo?
Would you be interested in participating in a vitiligo research study to test an investigational drug called afamelanotide?
Eligible patients will receive ultraviolet light therapy, either alone or in combination with afamelanotide.
You may be eligible to participate if you:
Have vitiligo on your face and body
Have a medium to dark skin type
Are able to attend up to 14 clinic visits over 12 months
Are aged 12+ Eligible patients will be reimbursed for their time.
Struggling with the pain and discomfort of acute gout flares? We're seeking participants for a clinical trial that could offer a new approach to managing this painful condition. If you've experienced multiple gout flare-ups in the past year, this is your chance to contribute to research focused on improving treatment options.
Key Inclusion Criteria:
Age: 18-70 years old (inclusive), male or female.
BMI: 18-40 kg/m² (inclusive).
Condition: Must have an established diagnosis of gout based on the American College of Rheumatology (ACR) criteria.
Experience: Have had 2 or more gout flares within the last 12 months.
What's in it for You:
Test a new investigational treatment designed to reduce the frequency and severity of acute gout flares.
Receive compensation for your time and involvement.
Help us make a difference for others living with gout.
Do migraines show up around your period? You're not alone; we're working on a better way to manage them.
We're inviting women to take part in a clinical research study looking at a new investigational medication for the intermittent prevention of menstrual migraine...
Interested in Taking Part? Start by Answering a Few Quick Questions
A clinical research study is now enrolling adults diagnosed with MDD to evaluate whether an investigational medication, taken alongside a standard antidepressant, may improve symptoms of depression. Participants will continue taking their existing antidepressant and receive either the study medication or a placebo (contains no active ingredients).Those who qualify may receive
If you are interested in participating in similar studies in the future, please register your interest in similar studies in the future
Are you aged 18 - 65 years with symptoms of OCD for at least one year (even without a formal diagnosis) and taking an anti-depressant that is not fully helping? Obsessive Compulsive Disorder (OCD) is a disorder that can affect men, women, and children, making them experience intrusive thoughts or compulsive behaviours and feel the need to perform specific tasks that become part of their routine repeatedly to relieve the distress caused by the obsession.
If you are interested in participating in similar studies in the future, please register your interest in similar studies in the future
Healthy volunteer for an Acute Gastroenteritis (Stomach bug) Clinical Trial
A Study to Evaluate the Efficacy and Safety of a Potential Vaccine Against Acute Gastroenteritis (Stomach bug/Stomach Flu) Caused by Norovirus in Adults ≥60 Years of Age in the United States.
Acute gastroenteritis (Stomach bug/Stomach Flu) is a medical condition characterized by digestive system inflammation, often resulting from a viral or bacterial infection. Common symptoms include diarrhoea, vomiting, and abdominal pain. Treatment usually involves rest, hydration, and, in some cases, medication.
This study aims to assess the effectiveness and safety of a vaccine designed to prevent acute gastroenteritis caused by norovirus in adults aged 60 and older. By participating, you will contribute to important medical research and help in the development of a potential new vaccine for norovirus.
Study Location
United States
Naperville, Illinois
Are you 18 years or older?
Are you diagnosed with IgAN from a kidney biopsy, or are you willing to have a biopsy if needed?
This study will evaluate a study drug versus placebo given every 4 weeks to people with immunoglobulin A nephropathy (IgAN) to learn if it impacts the disease.
Join the RAINIER Study, an IgAN autoimmune disease clinical trial.
Study Participants may receive:
Study drug or placebo (which contains no active ingredients)
Support from a specialized study team
Reimbursement for travel and study participation expenses
An opportunity to help advance rare autoimmune disease research
Study Locations
United States
Naperville, Illinois |
Hamilton, New Jersey
Are you aged 40 - 85 years with a diagnosis of COPD for at least a year and interested in participating in clinical trial studies? If you are a smoker and suffer from mild to moderate chronic obstructive pulmonary disease (COPD), then this trial may be for you.
If you are interested in participating in similar studies in the future, please register your interest in similar studies in the future
Are you interested in participating in a Covid-19 Vaccine Booster Clinical Trial Study? Are you an adult, and have taken two primary covid-19 vaccinations and one booster dose? Or a child above 12 years of age and has taken two primary covid-19 vaccinations with or without a booster dose? You may be eligible to participate in the study.
If you are interested in participating in similar studies in the future, please register your interest in similar studies in the future
Study for Adults with Obesity or Excess Weight (Overweight)
For participants who are 18 to 75 years old and have a BMI greater than 30 or a BMI greater than 27 with at least one of the following conditions: high blood pressure, high cholesterol, heart disease, or obstructive sleep apnea. Eligible participants should not have had any significant weight changes in the past three months, should not have taken weight loss medications during this period, and should not have undergone or be planning to undergo bariatric surgery or the fitting of a weight loss device. Additionally, individuals with diabetes are not eligible. Participants must also be willing to use approved forms of contraception during the study. Further criteria will be assessed to confirm eligibility.
The study is investigating an investigational drug designed to mimic the effects of amylin, a hormone that signals fullness, delays gastric emptying, and lowers blood sugar levels. By working like amylin, the drug aims to help reduce food intake and promote weight loss. Participants in the study will receive a weekly injection of either the study drug or a placebo for up to 36 weeks (approximately eight months). If you are interested in participating in similar studies in the future, please register your interest in similar studies in the future
Recruitment for this study has ended but you can register your interest in future Dermatitis/Eczema trials.
Recruitment for this study has ended, but you can register your interest in similar future research studies.
Recruitment for this study has ended, but you can register your interest in similar future research studies.
Recruitment for this study has ended but you can register your interest in future Dermatitis/Eczema trials.
Recruitment for this study has ended but you can register your interest in future Type 2 diabetes trials.
If you are interested in participating in similar studies in the future, please register your interest in similar studies in the future
